Global

Program

Entrepreneurship

Solve - MIT - The Horizon Prize 2022 Movemeback African initiative cover image

Details

For the more than 400 million people living with rare diseases, the journey towards diagnosis is often long and complex. Even when a rare disease has been identified, treatment options are scarce—over 95% of rare diseases have no approved treatments. Meanwhile, people also need support while living with the symptoms of rare diseases and the possibility of disease progression.

Technology can be a powerful tool for optimizing the well-being of people living with rare diseases. Educational tools can help patients better understand their diagnosis, and peer support networks can address the isolation that can accompany such knowledge. For health care providers, using technology can support clinical decision making to serve their patients more effectively.

The Horizon Prize, powered by MIT Solve, seeks technology-based solutions that improve the quality of life of people who have been diagnosed with a rare disease. To that end, the Prize seeks solutions that:

  • Optimize holistic care for people with rare diseases—including physical, mental, social, and legal support
  • Support daily care management for patients and/or their caregivers
  • Mitigate barriers to accessing medical care after diagnosis which disproportionately affect disinvested communities and historically underrepresented identity groups
  • Enhance coordination of care and strengthen data sharing between health care professionals, specialty services, and patients
  • Empower patients with quality information about their conditions to fight stigma associated with rare diseases; and promote community and connection among rare disease patients and their advocates

Criteria

The Horizon Prize, powered by MIT Solve, seeks technology-based solutions that improve the quality of life of people who have been diagnosed with a rare disease. To that end, the Prize seeks solutions that:

  • Optimize holistic care for people with rare diseases—including physical, mental, social, and legal support
  • Support daily care management for patients and/or their caregivers
  • Mitigate barriers to accessing medical care after diagnosis which disproportionately affects disinvested communities and historically underrepresented identity groups
  • Enhance coordination of care and strengthen data sharing between health care professionals, specialty services, and patients
  • Empower patients with quality information about their conditions to fight the stigma associated with rare diseases; and
  • Promote community and connection among rare disease patients and their advocates
     

Benefits

  • $150,000 in prize funding is available for up to two solution teams selected for the 2022 Horizon Prize
  • Finalists will be invited to pitch their solutions to a panel of distinguished judges in September 2022
  • The Horizon Prize encourages and actively seeks solutions led by people with rare diseases and underrepresented groups and identities

About Solve - MIT

Solve is an initiative of the Massachusetts Institute of Technology (MIT) that advances solutions from tech entrepreneurs to address the world's most pressing problems. Solve issues four Challenges each year to find the most promising Solver teams that will drive lasting, transformational change. Solve then deploys its global community of private, public, and nonprofit leaders to form the partnerships these Solver teams need to scale their impact.